SCIENTIFIC ADVISORY BOARD
Dr. Thomas Franklin, PhD
Dr. Franklin is an accomplished and well-published cardiovascular physiologist with 34 years of experience as a researcher, educator, and technology administrator including 18 years with Indiana University School of Medicine, serving as CEO of the Texas Health Research Institute, and currently as Executive Vice President of research and regulatory affairs for Organ Transport Systems, Inc. Dr. Franklin received his Ph.D. in Physiology and Biophysics from the University of Illinois at Urbana-Champaign, his M.S. in Cardiovascular Physiology from Bowman Gray School of Medicine, and his B.S. in Biology from Wake Forest University. Dr. Franklin also has a grandson
DR. HARVEY LEVY, MD
Dr. Levy is a renowned metabolic physician at Children’s Hospital Boston and a Professor of pediatrics at Harvard Medical School with a specialty in Biochemical Genetics. Dr. Levy received his M.D from Medical College of Georgia, and is board certified in Pediatrics, Medical Genetics, and Clinical Biochemical Genetics.
Dr. Rodney Howell, MD
Dr. Howell is the Professor of Pediatrics and Chairman Emeritus, at the Miller School of Medicine of the University of Miami. He is certified by the American Board of Pediatrics and by the American Board of Medical Genetics in the area of Clinical Biochemical Genetics. Following service as the Joseph P. Kennedy Scholar in Mental Retardation, while a faculty member of the Johns Hopkins University School of Medicine, Dr. Howell became David R. Park Professor and Chairman of Pediatrics at the University of Texas Medical School at Houston.
Kathryn Moseley, MS, RD
Ms. Moseley is well known in the PKU community as a leading metabolic dietitian and is an Assistant Professor of Pediatrics at the Keck School of Medicine at the University of Southern California. She is currently the Chair of Public Policy for the American Dietetic Association Pediatric Nutrition Practice Group and President of the California Coalition for PKU and Allied Disorders. Kathryn received her B.S. in Dietetics and Food Service Administration at the California State University, Long Beach Ca., her M.S. in Human Nutrition at the University of New Haven. She also has an adult daughter with PKU.
Dr. Ray Stevens, PhD
Dr. Stevens is an internationally known and well published chemist and structural biologist who is focused on understanding and developing treatment options for various diseases and disorders. In 1997, he discovered the structure of phenylalanine hydroxylase (the protein responsible for PKU) and has helped lead to the development of Kuvan and PEG-PAL. He is currently a Professor at The Scripps Research Institute, a leading researcher and thought leader in the PKU community and currently sits on multiple editorial boards. Dr. Stevens received his B.A. from University of Southern Maine and a Ph.D. from University of Southern California followed by National Institutes of Health Postdoctoral Fellowship at Harvard University.
Dr. Bryan Hainline, MD, PhD
Dr. Bryan Hainline is the Director at the Division of Clinical and Biomedical Genetics and the Medical Director of the Indiana University Genetic Counseling Program. Dr. Hainline received his MD and PhD degrees at Duke University, North Carolina. Dr. Hainline completed his pediatric internship and residency at the St. Louis Children's Hospital, St. Louis, Missouri. He underwent fellowship training in clinical, biochemical and molecular genetics at Washington University School of Medicine. He is board certified by the American Board of Pediatrics, and the American Board of Medical Genetics, with certification in Clinical Genetics, and Biochemical/Molecular Genetics.
Dr. Uta Lichter-Konecki, MD, PhD
Dr. Uta Lichter-Konecki is the Director of the Metabolism Program, Section of Neurology at St. Christopher's Hospital for Children in Philadelphia, PA. She earned her medical degree at the University of Heidelberg and her doctorate in medicine in the Department of Pediatrics at the University with a neuropediatrics and pediatric oncology related theme and completed her training in pediatrics and metabolic diseases. After her family moved to the United States, she enrolled in the Metropolitan Washington DC Medical Genetics Training program at the National Human Genome Research Institute and became board certified in clinical genetics in 2002 and in clinical biochemical genetics in 2005. She has 20 years of research and clinical experience in inborn errors of metabolism in both Europe and the US.
Dr. Denise M. Ney, PhD, RD
Dr. Denise M. Ney is a Professor of Nutritional Sciences and a Waisman Center investigator at the University of Wisconsin-Madison. She is a RD and completed a MS studying genetic metabolic disorders with Dr. William Nyhan at the University of California-San Diego in 1982. Dr. Ney received a PhD in nutrition from the University of California-Davis and joined the faculty at the University of Wisconsin-Madison in 1986. Denise’s research program addresses gastrointestinal physiology and the nutritional management of phenylketonuria (PKU). The PKU research has resulted in a new option for the nutritional management of PKU using glycomacropeptide (GMP), a protein found in cheese whey that is naturally low in phenylalanine. Dr. Ney directs a clinical trial funded by the FDA to compare the efficacy of the GMP and amino acid diets in PKU subjects living at home. The etiology of osteopenia in PKU is being studied in her laboratory using PKU mice fed GMP or amino acid diets, as previously supported by a NPKUA research grant. Dr. Ney received the 2012 Spitze Land Grant Faculty Award for Excellence in recognition of her breadth of teaching achievements and the relevance and impact of her research. She was also recognized as a Rare Disease Hero by the FDA in honor of the 30th anniversary of the Orphan Drug Act in 2013.
DR. Erin MacLeod, PHD, RD, LD
Dr. Macleod received her PhD from the University of Wisconsin Madison in 2010 where her primary research focus was the nutritional management of PKU. She participated in the clinical trials for glycomacropeptide and conducted a study to examine the change in phenylalanine tolerance in adults with PKU. Since that time she has been the Director of Metabolic Nutrition in the Division of Genetics and Metabolism at Children’s National Health System in Washington DC. In her current position Erin is part of an experienced clinical team who manage over 400 patients with inborn errors of metabolism and participate in a variety of clinical research projects.